Pelican Therapeutics' Corporate Majority Round

Pelican Therapeutics raised a round of funding on March 08, 2017. Investors include Heat Biologics.

Pelican Therapeutics is developing biologic agents that represent the next generation of TNF based immunotherapy. TNFRSF25 agonists provide a CD8+ T cell and Th1-type antibody adjuvant signal when use…

Articles about Pelican Therapeutics' Corporate Majority Round: